Detalhe da pesquisa
1.
Less Is More: When to Repeat Antimicrobial Susceptibility Testing.
J Clin Microbiol
; 61(8): e0046323, 2023 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37436180
2.
Predictive Modeling to Study the Treatment-Shortening Potential of Novel Tuberculosis Drug Regimens, Toward Bundling of Preclinical Data.
J Infect Dis
; 225(11): 1876-1885, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33606880
3.
Delamanid or pretomanid? A Solomonic judgement!
J Antimicrob Chemother
; 77(4): 880-902, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089314
4.
Superior Efficacy of a Bedaquiline, Delamanid, and Linezolid Combination Regimen in a Mouse Tuberculosis Model.
J Infect Dis
; 224(6): 1039-1047, 2021 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502537
5.
Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.
J Antimicrob Chemother
; 74(10): 2930-2933, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31236595
6.
Assessment of the Additional Value of Verapamil to a Moxifloxacin and Linezolid Combination Regimen in a Murine Tuberculosis Model.
Antimicrob Agents Chemother
; 62(9)2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29987154
7.
A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.
J Antimicrob Chemother
; 73(2): 437-447, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29136155
8.
Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis.
Am J Respir Cell Mol Biol
; 56(2): 233-241, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27654457
9.
Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.
Antimicrob Agents Chemother
; 61(10)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28739784
10.
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro.
Antimicrob Agents Chemother
; 60(4): 2577-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26883697
11.
Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.
J Antimicrob Chemother
; 70(10): 2828-37, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26183185
12.
Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model.
Am J Respir Crit Care Med
; 187(10): 1127-34, 2013 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23525933
13.
Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB.
Emerg Infect Dis
; 18(4): 660-3, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22469099
14.
Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 56(9): 4937-44, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22802244
15.
Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies.
Front Pharmacol
; 13: 1063453, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36569287
16.
Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps.
J Glob Antimicrob Resist
; 31: 345-352, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36347496
17.
Treatment and Outcome of Culture-Confirmed Mycobacterium marinum Disease.
Open Forum Infect Dis
; 9(4): ofac077, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35308482
18.
The association of body temperature with antibiotic therapy and mortality in patients attending the emergency department with suspected infection.
Eur J Emerg Med
; 28(6): 440-447, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33899772
19.
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).
Nat Commun
; 12(1): 267, 2021 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431879
20.
Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.
J Antimicrob Chemother
; 65(12): 2582-9, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20947621